Read more:
Eyenovia to Report Third Quarter 2020 Results on Tuesday, November 10
Author Archives: Fredricko
Biosyent Announces Launch of New FeraMAX® Pd Therapeutic 150
View original post here:
Biosyent Announces Launch of New FeraMAX® Pd Therapeutic 150
X4 Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Catalyst Biosciences Reports Third Quarter 2020 Operating & Financial Results and Provides a Corporate Update
Vericel Reports Record Third Quarter Revenues and Net Income
CalciMedica Appoints Daniel Geffken as Interim Chief Financial Officer
Read more from the original source:
CalciMedica Appoints Daniel Geffken as Interim Chief Financial Officer
Replimune Reports Fiscal Second Quarter Financial Results and Provides Corporate Update
See the original post:
Replimune Reports Fiscal Second Quarter Financial Results and Provides Corporate Update
Arch Biopartners Announces Dosing of First Patient in Turkey in Phase II Trial of LSALT peptide to Treat Complications from Covid-19
Outlook Therapeutics Secures $10 Million in Additional Working Capital
Yield10 Bioscience to Announce Third Quarter 2020 Financial Results and Host a Conference Call on Thursday, November 12, 2020
Enlivex Receives Notice of Allowance for U.S. Patent Application Covering Methods of Treating Gout, Inflammatory Bowel Disease, Crohn’s Disease, and…
Bellerophon Provides Clinical Program Update and Reports Third Quarter 2020 Financial Results
Go here to read the rest:
Bellerophon Provides Clinical Program Update and Reports Third Quarter 2020 Financial Results
Genmab Announces Phase 3 Study Evaluating Epcoritamab in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma
Catalyst Biosciences Announces Poster Presentation at the 62nd Annual American Society of Hematology Conference
Roche to present new data across 16 blood disorders at the American Society of Hematology 2020 Annual Meeting
Adamis Pharmaceuticals Schedules Third Quarter 2020 Results Conference Call and Business Update
Capricor Therapeutics to Present Third Quarter 2020 Financial Results and Recent Corporate Update on November 12
Gritstone Oncology Reports Third Quarter Financial Results and Recent Highlights
See the original post:
Gritstone Oncology Reports Third Quarter Financial Results and Recent Highlights
Homology Medicines Announces Upcoming Oral Presentation on pheNIX Gene Therapy Clinical Trial for Adults with PKU
Cyclacel Pharmaceuticals to Release Third Quarter Financial Results
See the rest here:
Cyclacel Pharmaceuticals to Release Third Quarter Financial Results